Results 181 to 190 of about 486,458 (259)

Severity of Clinical Presentation and Outcomes in Hospitalized Adult Patients with Influenza by Type and Subtype, United States-2017-2020. [PDF]

Clin Infect Dis
Cleary S, Lewis NM, Talbot HK, Zhu Y, Martin ET, Monto AS, Gaglani M, Murthy K, Zimmerman RK, Silveira FP, Tenforde MW, Patel MM, Ellington S, Olson SM.   +13 more
europepmc   +1 more source

The Risk of Narcolepsy Following Receipt of Adjuvanted Pandemic 2009 The Subtype of Influenza A Virus (H1N1) Vaccines: Results of the SOMNIA Global Collaborative Study

, 2016
Steven Black, Miriam Sturkenboom, Jan Bonhoeffer, Frank DeStefano, Tom T. Shimabukuro, Caitlin Dodd, Maria de Ridder, Daniel Weibel, Ángela Gentile, Norberto Giglio, Salaheddin M. Mahmud, Lawrence W. Svenson, Bruce Carleton, Monika Naus, Jeffrey C. Kwong, Brian Murray, Lisen Arnheim‐Dahlström, Lars Jacob Tynes Pedersen, Wan‐Ting Huang, Maria Goner-Soriano, Silvia Pérez-Vilar, Gert Jan Lammers, Sebastian Overeem, Alexandre Datta, Ulf Kallweit   +24 more
openalex   +1 more source

Real-World Effectiveness of Seasonal Influenza Vaccines During the 2024-2025 Season: Subgroup Analyses by Virus Subtype, Time Since Vaccination, and Diagnostic Method. [PDF]

Vaccines (Basel)
Choi YJ, Lee J, Song JY, Wie SH, Lee J, Lee JS, Jeong HW, Eom JS, Sohn JW, Yoon YK, Choi WS, Nham E, Yoon JG, Noh JY, Park MS, Cheong HJ.   +15 more
europepmc   +1 more source

Stimulation of Peripheral Blood Mononuclear Cells with <i>Lactococcus lactis</i> Strain Plasma Elicits Antiviral Effects Against H1N1 and SARS-CoV-2. [PDF]

Int J Mol Sci
Low ZX, Woo O, Kanauchi O, Hassandarvish P, Tiong V, AbuBakar S.   +5 more
europepmc   +1 more source

Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023-2024 Season. [PDF]

Clin Infect Dis
Chung JR, Price AM, Zimmerman RK, Moehling Geffel K, House SL, Curley T, Wernli KJ, Phillips CH, Martin ET, Vaughn IA, Murugan V, Scotch M, Saade EA, Faryar KA, Gaglani M, Ramm JD, Williams OL, Walter EB, Kirby MK, Keong LM, Kondor R, Ellington SR, Flannery B.   +22 more
europepmc   +1 more source

Influenza PA Substitutions and Genetic Diversity of A(H1N1)pdm09, A(H3N2), and B/Victoria Viruses in Japan During the 2023-2024 Season. [PDF]

Viruses
Lee N, Tang JW, Chon I, Kakuya F, Terao R, Kawashima T, Sato I, Kodo N, Suzuki E, Masaki H, Asoh N, Shirahige Y, Hamabata H, Tamura T, Wagatsuma K, Sun Y, Li J, Purnama TB, Ichikawa Y, Watanabe H, Saito R.   +20 more
europepmc   +1 more source

Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung

, 2018
Kathryn A. Ryan, Gillian S. Slack, Anthony C. Marriott, Jennifer A. Kane, Catherine Whittaker, Nigel Silman, Miles W. Carroll, Karen E. Gooch   +7 more
openalex   +2 more sources

Whole-genome analysis of influenza A(H1N1)pdm09 viruses in Cameroon (2019-2024) using nanopore sequencing. [PDF]

BMC Infect Dis
Tsafack DT, Monamele CG, Koro Koro F, Essengue LLM, Mounchili-Njifon A, Esso L, Njankouo Ripa M, Touoyem PI, Mouliem JLM, Tamoufe U, Moumbeket-Yifomnjou MH, Njouom R.   +11 more
europepmc   +1 more source

Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation in England: 2022/2023 and 2023/2024 Seasons. [PDF]

Influenza Other Respir Viruses
Whitaker HJ, Kirsebom FCM, Hassell K, Quinot C, Stowe J, Hoschler K, Zambon M, Andrews NJ, Watson CH, Lopez Bernal J.   +9 more
europepmc   +1 more source

A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance. [PDF]

Nat Commun
Zhang L, Shao Y, Zou X, Cui Y, Ding S, Chen Y, Wu Q, Mu S, Li X, Yang Q, Cao B, Deng T.   +11 more
europepmc   +1 more source